Paul Horstmeier Health Catalyst, Inc. (HCAT) insider trading activity

Paul Horstmeier is Chief Operating Officer of Health Catalyst, Inc.. Currently has a direct ownership of 204,880 shares of HCAT, which is worth approximately $1.59 Million. The most recent transaction as insider was on Sep 07, 2021, when has been sold 6,063 shares (Common Stock) at a price of $15.84 per share, resulting in proceeds of $96,038. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 205K

0% 3M change

0% 12M change

Total Value Held $1.59 Million

Paul Horstmeier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 07 2021	BUY Exercise of conversion of derivative security	$96,038 $15.84 p/Share	6,063 Added 4.93%	117,039 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$116,757 $54.23 p/Share	2,153 Reduced 1.9%	110,976 Common Stock
Aug 05 2021	SELL Open market or private sale	$603,075 $56.1 p/Share	10,750 Reduced 8.68%	113,129 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 7.98%	123,879 Common Stock
Jul 06 2021	SELL Open market or private sale	$612,105 $56.94 p/Share	10,750 Reduced 8.68%	113,129 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 7.98%	123,879 Common Stock
Jun 07 2021	SELL Open market or private sale	$475,011 $55.01 p/Share	8,635 Reduced 7.09%	113,129 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$96,038 $15.84 p/Share	6,063 Added 4.74%	121,764 Common Stock
Jun 01 2021	SELL Payment of exercise price or tax liability	$113,956 $53.88 p/Share	2,115 Reduced 1.8%	115,701 Common Stock
May 05 2021	SELL Open market or private sale	$543,931 $55.3 p/Share	9,836 Reduced 7.71%	117,816 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$138,600 $15.84 p/Share	8,750 Added 6.41%	127,652 Common Stock
Apr 05 2021	SELL Open market or private sale	$278,922 $48.09 p/Share	5,800 Reduced 4.65%	118,902 Common Stock
Mar 05 2021	SELL Open market or private sale	$298,915 $45.49 p/Share	6,571 Reduced 5.01%	124,702 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$69,603 $49.12 p/Share	1,417 Reduced 1.07%	131,273 Common Stock
Feb 18 2021	BUY Grant, award, or other acquisition	-	60,000 Added 31.14%	132,690 Common Stock
Feb 01 2021	SELL Open market or private sale	$533,523 $49.63 p/Share	10,750 Reduced 12.88%	72,690 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 11.41%	83,440 Common Stock
Jan 04 2021	SELL Open market or private sale	$462,465 $43.02 p/Share	10,750 Reduced 12.88%	72,690 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 11.41%	83,440 Common Stock
Dec 02 2020	SELL Open market or private sale	$303,851 $35.48 p/Share	8,564 Reduced 10.54%	72,690 Common Stock
Dec 01 2020	SELL Open market or private sale	$380,765 $35.42 p/Share	10,750 Reduced 11.68%	81,254 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 10.46%	92,004 Common Stock
Nov 02 2020	SELL Open market or private sale	$365,178 $33.97 p/Share	10,750 Reduced 11.68%	81,254 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 10.46%	92,004 Common Stock
Oct 01 2020	SELL Open market or private sale	$393,450 $36.6 p/Share	10,750 Reduced 11.68%	81,254 Common Stock

Paul Horstmeier

Chief Operating Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account